News
5h
News Medical on MSNNew drug strategy blocks cancer cells' adaptation, doubling chemotherapy effectivenessIn a wholly new approach to cancer treatment, Northwestern University biomedical engineers have doubled the effectiveness of ...
A new study by Indiana University School of Medicine researchers has revealed a breakthrough in the fight against acute myeloid leukemia, one of the most aggressive and fatal blood cancers in adults.
23h
News-Medical.Net on MSNRadiation primes the immune system to attack lung tumors resistant to immunotherapyBy sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to ...
From cell-manufacturing laboratories to outpatient infusion facilities, health systems are rapidly adapting to a new kind of cancer treatment that demands individualized care, infrastructure and ...
Replimune faces FDA hurdles for RP1, an innovative melanoma treatment, as it seeks a path forward after receiving a complete ...
Scancell has linked iSCIB1+ to a 69% response rate in advanced melanoma, lead | Scancell has linked iSCIB1+ to a 69% response ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results